(S)-4-Isopropyl-2-(pyridin-2-ylmethyl)-4,5-dihydrooxazole, 97%, 1g

Dimethyl benzylphosphonate, 95.0%, 25g

4-Bromo-2-hydroxypyridine, 95.0%, 1g

N,N-Dimethyl-2-cyanoacetamide, 95.0%, 5g

4,4-Difluoro-N-methylcyclohexanamine hydrochloride, 95%, 500mg

4-CHLORO-5-IODO-7-ISOPROPYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 1g

Acide 3-bromobenzoïque, min 99 %, pour la synthèse, 25 g, emballage en verre

Fermeture à charnière pliante PP noir 24/410 rond

4-(4-Oxopiperidin-1-ylcarbonyl)benzeneboronic acid, 95.0%, 5g

(S)-Methyl 2-amino-3-(2,4-dichlorophenyl)propanoate, 98%, 1g

(E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride, 95.0%, 25g

2-(3,3-Difluorocyclobutyl)ethanol, 95.0%, 500mg

8-Methoxy-1',3',3'-trimethyl-6-nitrospiro[chromene-2,2'-indoline], 98+%, 1g